• Friday, December 03, 2021
India Corona Update 
Total Fatalities 469,724
Total Cases 34,606,541
Today's Fatalities 477
Today's Cases 9,765
Pakistan Corona Update 
Total Fatalities 418,480
Total Cases 31,216,337
Today's Fatalities 3,998
Today's Cases 42,015
Sri Lanka Corona Update 
Total Fatalities 418,480
Total Cases 31,216,337
Today's Fatalities 3,998
Today's Cases 42,015
Bangladesh Corona Update 
Total Fatalities 418,480
Total Cases 31,216,337
Today's Fatalities 3,998
Today's Cases 42,015
UK Corona Update 
Total Fatalities 418,480
Total Cases 31,216,337
Today's Fatalities 3,998
Today's Cases 42,015
India corona update 
Total Fatalities 469,724
Total Cases 34,606,541
Today's Fatalities 477
Today's Cases 9,765

HEADLINE STORY

India shows greenlight to Johnson & Johnson’s single-dose vaccine

FILE PHOTO: Melissa Owens, operations plant manager for the McKesson Corporation, signs the first shipping box of the Johnson & Johnson COVID vaccine on March 1, 2021 in Shepherdsville, Kentucky. (Photo by Timothy D. Easley-Pool/Getty Images)

By: Pramod Thomas

INDIAN health minister on Saturday (7) said that the country has approved Johnson & Johnson’s single-dose Covid-19 vaccine for emergency use. This is the fifth vaccine approved in the country.

Mansukh Mandaviya said that this will further boost the country’s collective fight against the deadly disease.

“India expands its vaccine basket! Johnson and Johnson’s single-dose Covid-19 vaccine is given approval for emergency use in India. Now India has five EUA vaccines. This will further boost our nation’s collective fight against #Covid-19,” Mandaviya tweeted.

Indian health authorities have so far approved the use of vaccines developed by AstraZeneca, Bharat Biotech, Russia’s Gamaleya Institute, and Moderna.

The pharmaceutical giant had applied for emergency use approval of its vaccine, the company had said on Friday (6). The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, the company had said.

Earlier, India had announced that Covid-19 vaccines which were approved for restricted use by regulators in the US, UK, Europe, and Japan, or which were on the WHO’s emergency use listing, would not have to conduct bridging clinical trials in India.

“The US-based pharmaceutical company had applied for Emergency Use Authorisation for its jab on Friday and was granted the approval the same day by the Drugs Controller General of India (DCGI),” a senior official told PTI.

India on Saturday reported 38,628 new coronavirus cases, taking the infection tally to 31,895,385, while the death toll climbed to 427,371 with 617 fresh fatalities, according to the health ministry.

India has reported an average of 30,000 to 40,000 new coronavirus cases every day since July, and the federal government has warned that although cases have dipped from a high of 400,000 daily at the peak of the deadly second wave, the danger has not abated yet.

Eastern Eye

Related Stories

Eastern Eye

Videos

Mrunal Thakur on Dhamaka, experience of working with Kartik Aaryan,…
Nushrratt Bharuccha on Chhorii, pressure of comparison with Lapachhapi, upcoming…
Abhimanyu Dassani on Meenakshi Sundareshwar, how his mom Bhagyashree reacted…